PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2020

Apr 6, 2020

SEC Form 4/A — Form 4/A

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2020-02-25

Reporting Person: HUNT DOUGLAS M (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-25	Common Stock	A	4500	$0.00	Acquired	57330	Direct

Footnotes

F1: Shares issued pursuant to performance based vesting of restricted stock units.